MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.050
+0.010 (0.96%)
At close: Nov 6, 2026, 4:00 PM EST
1.060
+0.010 (0.95%)
After-hours: Nov 6, 2026, 4:10 PM EST
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $63.87 million as of November 6, 2026. It is the 28,147th most valuable company in the world and the 4,406th biggest in the United States. Its market cap has increased by 69.05% in one year.
Market Cap
63.87M
Enterprise Value
36.27M
1-Year Change
69.05%
Global Rank
Country Rank
#4,406 United States
Category
ChartMarket Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $63.87M, an increase of 24.98%. That is a compound annual growth rate of 5.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 63.87M | 9.09% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 67.77M |
| Acrivon Therapeutics | 67.28M |
| Champions Oncology | 66.25M |
| Coya Therapeutics | 65.92M |
| Conexeu Sciences | 65.36M |
| Cingulate | 61.66M |
| Fortress Biotech | 61.37M |
| Cognition Therapeutics | 60.42M |